INTRODUCTION
In western and Asian countries, changes in the diet and lifestyle have caused a noteworthy increase in the prevalence of obesity and metabolic syndrome, which has appreciably increased the incidence of non-alcoholic fatty liver disease (NAFLD). The NAFLD comprises of non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). The NAFL tends to be benign and non-progressive while the NASH can lead to development of cirrhosis and in rare cases gives rise to hepatocellular carcinoma. NAFLD occurs worldwide, with a prevalence ranging 10-50%. NAFLD is emerging as an important cause of liver disease in India with prevalence of 9% to 32% associated with obesity and Diabetes Mellitus. 1, 2, 3 NAFLD is increasingly prevalent in the Indian population, acquaintance regarding its burden and risk factors is limited. NAFLD and type 2 Diabetes Mellitus seems to be a costly and notorious combination of risk factors for various diseases. The NAFLD is commonly linked with type 2 DM despite the fact that its prevalence is not studied well in Indian context. This hospital based crosssectional study was conducted to estimate the frequency and prevalence of NAFLD in subjects with type 2 DM. Study aimed to evaluate the prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and associated demographic, metabolic and biochemical parameters in subjects with type -2 Diabetes Mellitus in a tertiary care centre, teaching hospital.
NAFLD-diagnostic criteria:
Alcohol consumption <20g/d, USG abdomen suggestive of fatty liver. The USG abdomen for detection of Fatty liver was performed by using B mode Siemens X -300 machine (3.5 -5 MHz convex probe). 6, 7 Hepatic steatosis if present, was classified based on standard ultrasonographic criteria as:
Grade 1 (mild steatosis): Normal visualization of diaphragm/ intrahepatic vessels.
Grade 2 (moderate steatosis): Impaired visualization of diaphragm/ intrahepatic vessels and
Grade 3 (severe steatosis): Poor visualization of diaphragm/ intrahepatic vessels. 6, 7 
STATISTICAL ANALYSIS
Statistical analysis was done by using the Statistical Package for Social Science (SPSS version 16) trial version. Basic descriptive statistical analysis of the quantitative variables was performed in the form of frequencies, means, percentage, standard deviations, Odds ratio (OR), Relative risk (RR) and chi-square test. The continuous variables were shown as mean ± standard deviation (SD). The P values < 0.05 were considered as significant.
RESULTS
A total 170 subjects of both genders were enrolled for this [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] The severity and grades of NAFLD was statistically significantly associated with BMI > 25 Kg/M 2 (p<0.001). The NAFLD was significantly associated with BMI >25 Kg/M 2 (p= 0.05866). The severity and grades of NAFLD was statistically significantly associated with duration of diabetes (p<0.001). The presence of NAFLD was statistically significantly associated with duration (>10 years) of diabetes (p<0.001). The severity and grades of NAFLD was not statistically significantly associated with age (p=0.9631406). The presence of NAFLD was statistically significantly associated with age > 45 years (p=0.03886854). (Table 4) The severity and grades of NAFLD was not statistically significantly associated with high total cholesterol (p=0.07340511). The NAFLD was not statistically significantly associated with total cholesterol >150 mg (p=0.63183404). The severity and grades of NAFLD was not statistically significantly associated with serum triglyceride level >150 mg (p=0.06245557). of NAFLD was not significantly associated with gender (p=0.447021). (Table 3) Correlation coefficient: There was statistically significant positive correlation between different grades of non-alcoholic fatty liver and HbA1c (+0.25124), BMI (+0.34743), BSL (F) (+0.0767), BSL (PP) (+0.16249), serum HDL level (+0.09981), SGOT/AST level (+0.14338), SGPT/ALT (+0.06392) and duration of diabetes (+0.4237). There was significant negative correlation between different grades of non-alcoholic fatty liver and serum triglyceride (-0.0048), age (-0.0205), systolic blood pressure (-0.052), diastolic blood pressure (-0.0283), total bilirubin level (-0.0431) and weight (-0.1596). (Table 5 ) In multivariate analysis after controlling age and gender there was statistically significant association between NAFLD (grade 2 fatty liver) and BMI, duration of Diabetes Mellitus and HbA1c (p<0.01). Male gender, age > 45, HbA1c> 6.5, BMI > 25 Kg/M 2 , duration of Diabetes Mellitus > 10 years together were as a risk factors associated significantly with presence of NAFLD in present study (p=0.0002). (Table 5 and graph 2)
DISCUSSION
Non-alcoholic fatty liver disease (NAFLD) was a distinct hepatic condition that was strongly associated with insulin resistance and type 2 Diabetes Mellitus. NAFLD has become an important health issue globally. The NAFLD is increasingly seen to be associated with metabolic syndrome. There are limited number of studies on epidemiology and natural history of NAFLD in diabetes. In the present cross-sectional observational study a total 170 subjects of both genders were enrolled of them 106 (62.35%) were males and 64 (37.64%) were females (p<0.0001). The HbA1c >6 had statistically significant association with presence of NAFLD in present study (p=0.028). Overall prevalence of NAFLD was 55.29% (94/170). The prevalence of NAFLD was 57.54% (61/106) and 51.56% (33/64) in males and female respectively. The NAFLD was statistically significantly associated with BMI >25 Kg/M 2 (p= 0.058). The severity and grades of NAFLD was statistically significantly associated with BMI > 25 Kg/ M 2 (p<0.001), duration of Diabetes Mellitus (>10 years) (p<0.001), age > 45 years (p=0.038) and triglyceride > 150 mg (p=0.034). Present study cannot be exactly compared with other studies from India and overseas because of different criterion for enrolment of subject for study, difference of criteria for diagnosing NAFLD, community based, different geographic area and genetic makeup of study population. Chen CH et al in their cross-sectional community based study of 3245 adults of Taiwan quoted prevalence of NAFLD of 11.5%. NAFLD was closely associated with obesity and Diabetes Mellitus. This prevalence is relatively low compared to present study [55.29% (94/170)] as it was hospital based study included only subjects with type 2 DM. The other parameters like obesity (BMI) (p<0.001) and hypertriglyceridemia (p=0.034) are comparable with present study. 8 Younossi ZM et al quoted prevalence of NAFLD in Asian countries varies from 9-40% and in western countries from 15-40%. In India, the prevalence of NAFLD was around 9-32% in the general population, but it was 12.5-87.5% in subjects with type 2 DM. 9 These findings are comparable with present study (55.29%). Majumdar A et al (2016) studied 176 participants with prevalence of NAFLD was 30.7% and was associated with central obesity. In current study the prevalence of NAFLD was quite high (55.29%) may be due to only cohort of type-2 DM were included. Association of BMI with NAFLD in present study was significant, similar to study by Majumdar A et al. 10 Bhatt KN et al (2017) in their study of total 100 subjects of type 2 DM the prevalence of NAFLD was 45% with obesity (measured by BMI), higher HbA1c, higher triglyceride levels had significant association with NAFLD. 11 These findings are comparable with present study with prevalence of NAFLD of 55.29% and association of BMI, TRG, HbA1c was enough significant with NAFLD. Compared to present study (55.29%), Jaseem Ansari et al (2017) found 26% prevalence of NAFLD which was significantly low, could be due to different inclusion and exclusion criteria. 12 Lavekar A et al (2015) studied 302 individuals with prevalence of NAFLD of 28.1%, which was relatively low compared to our study as we have enrolled only type -2 DM subjects which is one of the proved risk factor for NAFLD. 13 Prabhakar A et al (2017) quoted prevalence of NAFLD was 41.2% in the study group (n=114), which is similar to present study. Prevalence of NAFLD was significantly associated with HbA1c, duration of diabetes and obesity, these findings are comparable with our study. 14 Gupta M et al (2017) in their hospital based observational descriptive study (n=150) in subjects with T2DM, 104 (69.33%) had fatty liver on USG, 42.67% had grade 1, 24% had grade 2, and the remaining 2.67% had grade 3 fatty changes in liver. 15 These findings are comparable with present study with overall prevalence of NAFLD of 55.29% (94/170). The NAFLD was statistically significantly associated with BMI >25 Kg/M 2 (p<0.001), duration (>10 years) of Diabetes Mellitus (p<0.001), age > 45 years (p=0.038) and triglyceride > 150 mg (p=0.034). Bhardwaj et al (2016) in their cross-sectional study (n=100) with subjects of type 2 diabetes, the prevalence of NAFLD was 61%. 16 These findings are similar to present study with prevalence of NAFLD of 55.29% (94/170). The NAFLD was statistically significantly associated with BMI > 25 Kg/M 2 , duration (>10 years) of diabetes, age >45 years and triglyceride >150 mg. Similarly Chandel K et al (2016) in their study of total of 185 diabetic and 105 non-diabetic subjects quoted prevalence of NAFLD in DM was 55.68% and in non-diabetic was 20%. 17 There is a paucity of data regarding the incidence of NAFLD in the general population. We compared the prevalence and risk factors of NAFLD in the general population with present study. (Table 6) Limitations of the study: This was a hospital based study and conducted only on cohort of type-2 Diabetes Mellitus subjects. The present study lacks histological evidence for NAFLD and improved imaging modality like MRI spectroscopy.
CONCLUSION
Present study highlighted the significant Non-Alcoholic Fatty Liver Disease burden in cohort of type-2 Diabetes Mellitus; about half of the subjects had NAFLD (55.29%). NAFLD and type 2 DM seems to be a costly combination of risk factors for various diseases. In present study high BMI,
